Losartan vs calcium channel blockers
Pro Research Analysisby 
Searched over 200M research papers
Tolerability and Side Effects: Losartan vs Calcium Channel Blockers
Research shows that losartan generally has better tolerability compared to calcium channel blockers (CCBs). In a large prospective study, the 3-month cumulative incidence of side effects was lower for losartan (52.5%) than for CCBs (69.6%). After adjusting for various factors, patients on CCBs had significantly higher odds of reporting side effects compared to those on losartan . Another study found that patients who switched from CCBs to losartan due to side effects like peripheral edema experienced similar blood pressure control with fewer adverse effects on losartan .
Blood Pressure Reduction Efficacy: Losartan vs Calcium Channel Blockers
Both losartan and CCBs are effective in lowering blood pressure. In direct comparisons, amlodipine (a CCB) produced slightly greater reductions in both systolic and diastolic blood pressure than losartan, though both drugs were effective for mild to moderate hypertension. The difference in the percentage of patients reaching blood pressure goals was not statistically significant, but amlodipine showed a trend toward higher response rates, especially in certain populations . When used in combination therapy, losartan with amlodipine was more effective in reducing 24-hour ambulatory blood pressure and blood pressure variability than losartan with a diuretic, particularly in men Cho2016Cho2016Cho2016.
Risk of Gout: Losartan and Calcium Channel Blockers
Both losartan and CCBs are associated with a lower risk of developing gout compared to other antihypertensive drugs. Long-term use of either drug further reduces this risk, which is attributed to their urate-lowering properties. In contrast, other antihypertensive classes, such as diuretics and non-losartan angiotensin II receptor blockers, are linked to a higher risk of gout .
Renal Protection: Losartan vs Calcium Channel Blockers
Losartan and some third-generation CCBs both offer renal protection, but their effects may differ depending on the clinical context. In animal models of chronic kidney disease, losartan was more effective than the CCB lacidipine in reducing proteinuria and preserving kidney structure, even when blood pressure control was similar . However, third-generation CCBs like lercanidipine, which block both L- and T-type calcium channels, may also provide significant renoprotective effects, especially when added to other renin-angiotensin system inhibitors .
Combination Therapy: Losartan with Calcium Channel Blockers
Combining losartan with a CCB (such as amlodipine) is often more effective for blood pressure control and reducing blood pressure variability than combining losartan with a diuretic. This combination is particularly beneficial for 24-hour blood pressure control and may offer additional cardiovascular protection Cho2016Cho2016Cho2016. Both combinations are generally safe, but the losartan/CCB combination may be preferred for patients at higher risk of cardiovascular events or those who experience side effects with other regimens .
Conclusion
Losartan and calcium channel blockers are both effective antihypertensive agents, but losartan tends to have better tolerability and a lower risk of gout. Calcium channel blockers may provide slightly greater blood pressure reductions in some patients, but losartan offers superior renal protection in certain settings. Combination therapy with losartan and a CCB is often more effective and better tolerated than other combinations, making it a strong option for many patients with hypertension.
Sources and full results
Most relevant research papers on this topic